Literature DB >> 16318891

Sensitivity of detection of rhinoviruses in spiked clinical samples by nucleic acid sequence-based amplification in the presence of an internal control.

Katherine Loens1, Margareta Ieven, Stefaan Pattyn, Peter Sillekens, Herman Goossens.   

Abstract

The objectives of the study were to determine the sensitivity of Nucleic Acid Sequence-Based Amplification (NASBA) for the detection of rhinovirus (RV) serotype 15 in water and in spiked respiratory specimens in the presence of a newly developed internal control (IC). The sensitivity of NASBA on RNA was 10 molecules per reaction. The sensitivity of RV NASBA on RV-15 in water and in respiratory specimens was equal to that in tissue culture. Addition of 10(4) molecules of rhinovirus internal control (RV IC) did not affect the sensitivity. Viral RNA should be extracted from clinical specimens as rapidly as possible after collection, since loss of detectable RNA occurs after 2 h. NASBA allows a sensitive detection of RV RNA in spiked respiratory specimens in the presence of an internal control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16318891     DOI: 10.1016/j.mimet.2005.10.012

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  2 in total

1.  Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season.

Authors:  K Loens; H Goossens; C de Laat; H Foolen; P Oudshoorn; S Pattyn; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Authors:  K Loens; T Beck; H Goossens; D Ursi; M Overdijk; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.